標(biāo)題: Titlebook: Amlodipine; Winifred G. Nayler Book 1993 Springer-Verlag Berlin Heidelberg 1993 Ca++-channel.Calcium-antagonist.PTCA.cardiovascular.hypert [打印本頁(yè)] 作者: 極大 時(shí)間: 2025-3-21 20:07
書(shū)目名稱Amlodipine影響因子(影響力)
書(shū)目名稱Amlodipine影響因子(影響力)學(xué)科排名
書(shū)目名稱Amlodipine網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Amlodipine網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Amlodipine被引頻次
書(shū)目名稱Amlodipine被引頻次學(xué)科排名
書(shū)目名稱Amlodipine年度引用
書(shū)目名稱Amlodipine年度引用學(xué)科排名
書(shū)目名稱Amlodipine讀者反饋
書(shū)目名稱Amlodipine讀者反饋學(xué)科排名
作者: DEVIL 時(shí)間: 2025-3-22 00:02 作者: 有特色 時(shí)間: 2025-3-22 01:25
Cell Membrane Transport,h are involved in transporting calcium ions across membranes — because if he had he might have chosen his words more carefully. The mechanisms which are involved in maintaining intracellular ionic homeostasis, particularly with respect to Ca. and Na., are complex but gradually the relative significa作者: insolence 時(shí)間: 2025-3-22 07:53
The Voltage-Activated, Calcium Antagonist-Sensitive Calcium Channels: Their Structure, Composition al more to write. In particular, before explaining how the cardiovascular system responds to the calcium antagonists and in particular to amlodipine — which is one of the most recent newcomers to the field and which seems to be excitingly different from it predecessors — it is probably useful to sum作者: beta-carotene 時(shí)間: 2025-3-22 10:48 作者: Exclaim 時(shí)間: 2025-3-22 15:24
,Amlodipine — A Long-Acting Second Generation Calcium Antagonist with an Unusual Binding Profile,ined during the early days of their clinical use pointed towards their potential value in other fields of medicine. Nowadays it is quite common to find drugs of this type being used in the management of patients with a relatively wide spectrum of disorders, ranging from hypertension to oesophageal a作者: 使殘廢 時(shí)間: 2025-3-22 17:06 作者: 鞠躬 時(shí)間: 2025-3-22 22:05 作者: Chipmunk 時(shí)間: 2025-3-23 02:28 作者: 鬼魂 時(shí)間: 2025-3-23 07:06
Calcium Antagonism and the Ischaemic Heart: Is Calcium Antagonism Relevant?,l haemodynamics and function (Chapter 10), and before considering their usefulness as blood pressure lowering agents — particularly with respect to their long term use in the management of patients with essential hypertension (Chapter 14), the logical question which emerges now concerns the feasibil作者: 固定某物 時(shí)間: 2025-3-23 11:07
,Calcium Antagonists and the Stunned Heart — Are Vascular Selective Antagonists Protective?,onary blood flow is severe and sustained, then the inevitable outcome is that the cells in the affected area are doomed to die and necrose, irrespective of whether the tissue is subsequently reperfused (Jennings et al., 1990). Not all episodes of ischaemia are sustained and severe, however. For exam作者: Focus-Words 時(shí)間: 2025-3-23 16:44 作者: 相信 時(shí)間: 2025-3-23 21:35 作者: 只有 時(shí)間: 2025-3-24 00:47 作者: Obstreperous 時(shí)間: 2025-3-24 04:01 作者: Obverse 時(shí)間: 2025-3-24 09:05
Calcium Antagonists and Heart Failure,idity and mortality. In America, for example, one percent of the population already suffers from the complaint, and there are approximately four hundred thousand new cases presenting for treatment each year. (Sonnenblick et al., 1991). Even more disturbing is the prediction that as therapy for the m作者: JOG 時(shí)間: 2025-3-24 13:52
The Side-Effects of Calcium Antagonist Therapy. Is Amlodipine Different?,ol would undoubtedly lack any appreciable side-effects. Unfortunately, and despite its obvious attraction, even the concept or a Utopian world is pure fantasy, as is the likelihood of effective therapeutic agents being developed which lack any side-effects. In reality physicians have had to cope wit作者: LARK 時(shí)間: 2025-3-24 16:48 作者: FLAT 時(shí)間: 2025-3-24 20:22
Erratum to: Die Stochastik der Iterationen, writing “Man and Superman”, because whilst it is a truism to say that . few investigators could have anticipated the recent developments which have taken place in the field of calcium antagonism. Not only was much of this progress unanticipated; at first sight it may even seem to be unreasonable. F作者: Phagocytes 時(shí)間: 2025-3-25 00:34 作者: Culpable 時(shí)間: 2025-3-25 06:20 作者: 尾隨 時(shí)間: 2025-3-25 07:38 作者: 保留 時(shí)間: 2025-3-25 15:00
https://doi.org/10.1007/978-3-642-94232-7section of the channel which contains the specific binding sites for the calcium antagonists (see Chapter 4) it is appropriate now to briefly consider the chemistry of these drugs. Even the most superficial consideration of this aspect of the calcium antagonists cannot help but reveal:作者: reaching 時(shí)間: 2025-3-25 15:57 作者: Tractable 時(shí)間: 2025-3-25 23:36 作者: 省略 時(shí)間: 2025-3-26 04:11
W. Schultz,G. Frhr. v. Seherr-Tho? (Chapter 7), coupled with its vascular selectivity (Chapter 8), this particular calcium antagonist would seem to be well suited for use in the long-term management of hypertensive patients and of patients with other cardiovascular disorders. It is worth considering, therefore, whether its pharmacok作者: mitral-valve 時(shí)間: 2025-3-26 07:16 作者: Fibrinogen 時(shí)間: 2025-3-26 08:56
Evelyn H. Schulz,Frank P. Sempertl haemodynamics and function (Chapter 10), and before considering their usefulness as blood pressure lowering agents — particularly with respect to their long term use in the management of patients with essential hypertension (Chapter 14), the logical question which emerges now concerns the feasibil作者: Resistance 時(shí)間: 2025-3-26 15:19 作者: frenzy 時(shí)間: 2025-3-26 16:49 作者: FLOUR 時(shí)間: 2025-3-26 21:05
https://doi.org/10.1007/978-3-642-45807-1ot seem to warrant consideration (Manda, 1991; McMahon et al., 1990; Collins et al., 1990). Trials of this nature started in the nineteen sixties when several hundred male subjects with severe hypertension were studied over a five year period during which time they were allocated to either placebo o作者: 承認(rèn) 時(shí)間: 2025-3-27 04:43 作者: 騎師 時(shí)間: 2025-3-27 06:29
https://doi.org/10.1007/978-3-642-99311-4n detail by Heberden, in the seventeen seventies (Heberden, 1772) and only a few years later its pathological basis was elucidated, albeit on a rather hypothetical basis and without the aid of modern technology which nowadays makes the diagnosis unequivocal. Early investigators in this particular fi作者: OPINE 時(shí)間: 2025-3-27 09:40
Die Jodzahl der Fette und Wachsartenidity and mortality. In America, for example, one percent of the population already suffers from the complaint, and there are approximately four hundred thousand new cases presenting for treatment each year. (Sonnenblick et al., 1991). Even more disturbing is the prediction that as therapy for the m作者: 凝結(jié)劑 時(shí)間: 2025-3-27 16:16 作者: 高貴領(lǐng)導(dǎo) 時(shí)間: 2025-3-27 20:08 作者: freight 時(shí)間: 2025-3-28 00:28
The Chemistry of the Calcium Antagonists,section of the channel which contains the specific binding sites for the calcium antagonists (see Chapter 4) it is appropriate now to briefly consider the chemistry of these drugs. Even the most superficial consideration of this aspect of the calcium antagonists cannot help but reveal:作者: 小歌劇 時(shí)間: 2025-3-28 05:07
,Calcium Antagonists and the Stunned Heart — Are Vascular Selective Antagonists Protective?,onary blood flow is severe and sustained, then the inevitable outcome is that the cells in the affected area are doomed to die and necrose, irrespective of whether the tissue is subsequently reperfused (Jennings et al., 1990). Not all episodes of ischaemia are sustained and severe, however. For example:作者: TOXIC 時(shí)間: 2025-3-28 10:10
http://image.papertrans.cn/a/image/154701.jpg作者: 充滿裝飾 時(shí)間: 2025-3-28 11:13 作者: 激怒某人 時(shí)間: 2025-3-28 15:23
The Vascular Selectivity of Amlodipine,Having established that amlodipine is a calcium antagonist which:作者: champaign 時(shí)間: 2025-3-28 22:25
https://doi.org/10.1007/978-3-642-78223-7Ca++-channel; Calcium-antagonist; PTCA; cardiovascular; hypertension作者: Mangle 時(shí)間: 2025-3-28 22:56
978-3-540-56698-4Springer-Verlag Berlin Heidelberg 1993作者: 串通 時(shí)間: 2025-3-29 06:27 作者: Melatonin 時(shí)間: 2025-3-29 11:06
Die Jahrhunderthalle in Breslau,onary blood flow is severe and sustained, then the inevitable outcome is that the cells in the affected area are doomed to die and necrose, irrespective of whether the tissue is subsequently reperfused (Jennings et al., 1990). Not all episodes of ischaemia are sustained and severe, however. For example:作者: 灌輸 時(shí)間: 2025-3-29 14:14
M. Schul?,G. Frhr. v. Seherr-Tho?marize what is known about the receptors with which these compounds interact. At the molecular level this means describing the structure and chemistry of the Ca. conducting channels because it is here that the high affinity “receptors” for these drugs are located.作者: SPURN 時(shí)間: 2025-3-29 17:07
https://doi.org/10.1007/978-3-642-45807-1 hypothermic climatic conditions”. To the cardiologist the term is applied specifically to the heart — and only under conditions in which a sustained reduction in coronary perfusion is the predominant cause of an adaptive process which results in down-regulation of the heart’s contractile activity.作者: 恭維 時(shí)間: 2025-3-29 20:58
https://doi.org/10.1007/978-3-642-45807-1 fashion” for treating hypertensives, because it revealed a cardiovascular morbidity of fifty-five percent in the placebo group, compared with only eighteen percent in patients receiving antihypertensive treatment. In addition cardiovascular mortality was reduced in the group receiving active therapy.作者: 清醒 時(shí)間: 2025-3-30 01:46
Amlodipine and the Hibernating Myocardium: Could It Be Beneficial?, hypothermic climatic conditions”. To the cardiologist the term is applied specifically to the heart — and only under conditions in which a sustained reduction in coronary perfusion is the predominant cause of an adaptive process which results in down-regulation of the heart’s contractile activity.作者: SLAG 時(shí)間: 2025-3-30 06:35
Calcium Antagonists and the Treatment of Hypertension, fashion” for treating hypertensives, because it revealed a cardiovascular morbidity of fifty-five percent in the placebo group, compared with only eighteen percent in patients receiving antihypertensive treatment. In addition cardiovascular mortality was reduced in the group receiving active therapy.作者: insular 時(shí)間: 2025-3-30 08:50 作者: 白楊魚(yú) 時(shí)間: 2025-3-30 15:52
Die Jodzahl der Fette und Wachsarten pathophysiology of heart failure, the annual mortality rate still ranges from between fifteen and fifty percent, depending on the severity and precise cause of the condition (Franciosa et al., 1983; Gheorghiade, 1992).作者: 山頂可休息 時(shí)間: 2025-3-30 19:58 作者: 禁止,切斷 時(shí)間: 2025-3-30 22:02 作者: Corral 時(shí)間: 2025-3-31 01:39 作者: scotoma 時(shí)間: 2025-3-31 06:23
Money Made Simple" 1989. The development of calcium antagonists has recently been described as representing "one of the major advances in cardiovascular thera- peutics of the latter half of the twentieth century" (Braunwald, 1990). However, although the development of these drugs started in the mid作者: Resistance 時(shí)間: 2025-3-31 09:56 作者: 龍卷風(fēng) 時(shí)間: 2025-3-31 14:33
